Matches in Nanopublications for { ?s ?p "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 23 of
23
with 100 items per page.
- NP565544.RAQ8Sq_6qiCTZUjtaCKlLzsnzd6K4MJ_NzToZwdfs81bQ130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565544.RAQ8Sq_6qiCTZUjtaCKlLzsnzd6K4MJ_NzToZwdfs81bQ130_provenance.
- NP264951.RAClmHZyxtQlJ2SMcUPpQGWub9AHyUUztNr3x5YYlbQuM130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264951.RAClmHZyxtQlJ2SMcUPpQGWub9AHyUUztNr3x5YYlbQuM130_provenance.
- NP372015.RA1iYOg7CwEBThFWK4fawrv74lDjw-YXvalKpJEKD7yZo130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372015.RA1iYOg7CwEBThFWK4fawrv74lDjw-YXvalKpJEKD7yZo130_provenance.
- NP407118.RAV3ls_h1Grwx0cQkIShKkNNkkpCkVvp270Mjg6FTR86A130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407118.RAV3ls_h1Grwx0cQkIShKkNNkkpCkVvp270Mjg6FTR86A130_provenance.
- NP747226.RA1lS7Qid1MlJTlJlZAiR8kbnA-1zQ3AykhZ7aWX2qskA130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747226.RA1lS7Qid1MlJTlJlZAiR8kbnA-1zQ3AykhZ7aWX2qskA130_provenance.
- NP781372.RAYOU49fzF2IYkDpcLD9NGwVc3Dn2urMdJw_iLvVZ4XtA130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781372.RAYOU49fzF2IYkDpcLD9NGwVc3Dn2urMdJw_iLvVZ4XtA130_provenance.
- NP978464.RAehz66ALhHKvbzyFkaSvwVBZ9zmtQ9BqQT1Lnjq_Kle4130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978464.RAehz66ALhHKvbzyFkaSvwVBZ9zmtQ9BqQT1Lnjq_Kle4130_provenance.
- NP557393.RALBLVXXB3L1W-PDSCzwV8Z_RU6q8LcxZnh56OR_QhZ4A130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557393.RALBLVXXB3L1W-PDSCzwV8Z_RU6q8LcxZnh56OR_QhZ4A130_provenance.
- NP966556.RAdtz6sCvaVvMkJuoGwEsTcts1JvxKjqoRI0Qe9E3K9hs130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966556.RAdtz6sCvaVvMkJuoGwEsTcts1JvxKjqoRI0Qe9E3K9hs130_provenance.
- NP966559.RARi693JJGMK0b20-KC0sJWIjAVUxmmMdyWypEiFTPYSw130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966559.RARi693JJGMK0b20-KC0sJWIjAVUxmmMdyWypEiFTPYSw130_provenance.
- NP966561.RAU7izBSlwFOhjkSAk3rQdzVxLwpen6m4PNQGfQpsbMiE130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966561.RAU7izBSlwFOhjkSAk3rQdzVxLwpen6m4PNQGfQpsbMiE130_provenance.
- NP407278.RAtjVpQ-SMXw0ai8ZL5Go6bL-RPDw9ifJJKoveuUqzpfU130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407278.RAtjVpQ-SMXw0ai8ZL5Go6bL-RPDw9ifJJKoveuUqzpfU130_provenance.
- NP873123.RAsCYOQGlzBtF5gAAhNIZLHtneeV7GNzd-OtrsfqYjK7k130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873123.RAsCYOQGlzBtF5gAAhNIZLHtneeV7GNzd-OtrsfqYjK7k130_provenance.
- NP966555.RAuuDbENpStxg44stuGm8gzD_Zdq56QqWdcgladWpF9nc130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966555.RAuuDbENpStxg44stuGm8gzD_Zdq56QqWdcgladWpF9nc130_provenance.
- NP966563.RAiDW2k6iP1s7fhrc81bfsRv0C-r5s86ArZ9UFjq2YW7E130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966563.RAiDW2k6iP1s7fhrc81bfsRv0C-r5s86ArZ9UFjq2YW7E130_provenance.
- NP605925.RA-YYAxgoR4YS8zT3Y5zaO7ST4L579oa22xeZIJzO680k130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605925.RA-YYAxgoR4YS8zT3Y5zaO7ST4L579oa22xeZIJzO680k130_provenance.
- NP683833.RAJQYsuWre2Mjxz0_xkUxYW3y-iQ2IvLyzCBaHI5H_w7c130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP683833.RAJQYsuWre2Mjxz0_xkUxYW3y-iQ2IvLyzCBaHI5H_w7c130_provenance.
- NP683724.RA1aQRalXii5ViTb1RfNj87TilLr9IgjWh_YzkqrHe570130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP683724.RA1aQRalXii5ViTb1RfNj87TilLr9IgjWh_YzkqrHe570130_provenance.
- NP966558.RANlQRI_aKzylEmXfNZi91BoMRk_qKmge_OIQ4tbeUTTQ130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966558.RANlQRI_aKzylEmXfNZi91BoMRk_qKmge_OIQ4tbeUTTQ130_provenance.
- NP966560.RAITzgj_y5JUrMsnikxYjOMMPpcXNF10eZ57glYHfteio130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966560.RAITzgj_y5JUrMsnikxYjOMMPpcXNF10eZ57glYHfteio130_provenance.
- NP913955.RA4RpKkm0CpxN41jCUTH4UljJ-vPWADiWO7jCIrN6BLhc130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913955.RA4RpKkm0CpxN41jCUTH4UljJ-vPWADiWO7jCIrN6BLhc130_provenance.
- NP966557.RA05leyhlGZEEQ8gGuzNgUT5pU2iijJqzGT57-KQA5OsA130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966557.RA05leyhlGZEEQ8gGuzNgUT5pU2iijJqzGT57-KQA5OsA130_provenance.
- NP966562.RA2fruURAYSUxqwarPd39VSlZFC9RRMyEIAruqwRmmzkI130_assertion description "[SCT from HLA-identical sibling donors is generally associated with an excellent survival in FA patients if performed prior to the development of MDS or leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966562.RA2fruURAYSUxqwarPd39VSlZFC9RRMyEIAruqwRmmzkI130_provenance.